Plaques, triggers, and modern management.
Blocking IL-23 has produced some of the best clearance figures in psoriasis and has always meant an injection. A peptide that survives digestion moves the whole access question.
Most psoriasis is treated topically for life, which makes the boring questions — what you remove first, which base you use where, and what you do in the clear weeks — the ones that decide the outcome.
Four drug targets, wildly different dosing schedules, and a set of comorbidities that quietly decide the shortlist before anyone discusses clearance rates with you.
A substantial share of people with psoriasis develop joint disease, a large fraction of them without anyone noticing. The damage that accumulates before diagnosis does not come back — and the screening questionnaire that catches it is five questions long.
Three of the most common red, scaly rashes get mixed up constantly — and the drugstore fix for one can actively inflame another. The tells are location, scale, and the way it itches.
It's an immune disease writing itself on your skin. Moisturizer won't fix that, but the right routine genuinely lowers flares and makes the real treatments work better.